BMO Capital Markets advice for Amgen
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| September 24, 2013 | BMO Capital Markets | Amgen | Hold | 116.00 USD |
Advice details
Montreal - Op 24 Sep 2013 herhalen de analisten van BMO Capital Markets hun houdadvies voor the American bio-technology company Amgen (ISIN: US0311621009 / Mnemo: AMGN). Het 12-maands koersdoel wordt opwaarts bijgesteld van 83.0 USD naar 116.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 